FDA Drug Center Would Lose 44 FTEs Under Fiscal 2005 Budget Request
Executive Summary
FDA's fiscal 2005 budget request includes a reduction of 44 full-time equivalent positions in the Center for Drug Evaluation & Research
You may also be interested in...
FDA ANDA Full Approvals Down In FY 2003, Total Applications Increase
The number of full generic drug approvals dropped slightly in fiscal 2003 to 284, compared to 296 in fiscal 2002
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials